Once-weekly alendronate: Two year subgroup efficacy analyses in postmenopausal women with osteoporosis.

被引：0
|
作者：
Bone, H
Felsenberg, D
Greenwald, M
Schnitzer, T
Kaur, A
Cudny, M
Peverly, C
Orloff, J
Santora, A
机构：
[1] Michigan Bone & Mineral Clin PC, Detroit, MI USA
[2] Free Univ Berlin Klinikum, Berlin, Germany
[3] Desert Med Advances, Palm Desert, CA USA
[4] Northwestern Univ, Chicago, IL 60611 USA
[5] Merck Res Labs, Rahway, NJ USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S526 / S526
页数：1
相关论文
共 50 条
  • [21] Efficacy, safety and tolerability of once weekly (80 mg vs. 160 mg) oral alendronate in postmenopausal osteoporosis.
    Brown, JP
    Banville, C
    Jean, S
    Drake, WM
    Kendler, DL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S528 - S528
  • [22] Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis
    Luckey, M
    Kagan, R
    Greenspan, S
    Bone, H
    Kiel, RDP
    Simon, J
    Sackarowitz, J
    Palmisano, J
    Chen, E
    Petruschke, RA
    de Papp, AE
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (04): : 405 - 415
  • [23] Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women
    Ho, AYY
    Kung, AWC
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1428 - 1433
  • [24] Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis
    Gerster, JC
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (04) : 829 - 830
  • [25] EFFICACY OF ONCE-WEEKLY RISEDRONATE IN MEN WITH OSTEOPOROSIS
    Zidrou, C.
    Neophytou, D. P.
    Kyriakidis, T.
    Alvanos, D.
    Kyriakidis, A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 343 - 343
  • [26] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Lewiecki, EM
    Rosen, C
    Bockman, RS
    Vanaman, LK
    Smith, ME
    Wang, L
    Thompson, D
    Yates, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S43 - S44
  • [27] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis
    Palmisano, J
    Melton, M
    Lewiecki, EM
    Rosen, R
    Bockman, RS
    Dinh, AC
    Smith, ME
    Wang, L
    Keene, W
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S36 - S36
  • [28] Improved patient satisfaction with once-monthly ibandronate in women previously receiving once-weekly alendronate or risedronate for postmenopausal osteoporosis or osteopenia.
    Bonnick, S. L.
    Tanner, S. B.
    Martens, M.
    Civitelli, R.
    Kornowski, A.
    Silverman, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S285 - S285
  • [29] Balto I: Patient preference and convenience study of once-monthly ibandronate versus once-weekly alendronate for the treatment of osteoporosis.
    Emkey, R
    Binkley, N
    Seidman, L
    Rosen, C
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S296 - S296
  • [30] Alendronate 35mg once-weekly treatment increased bone mineral density in Japanese patients with osteoporosis.
    Uchida, S
    Taniguchi, T
    Shimizu, T
    Kakikawa, T
    Okuyama, K
    Okaniwa, M
    Arizono, H
    Nagata, K
    Santora, A
    Shiraki, M
    Fukunaga, M
    Tomomitsu, T
    Ohashi, Y
    Nakamura, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S278 - S279
12345